Physician profile
Sam Mark
NPI 1770014193
$3,243.15
in general payments reported to CMS, 2019-2025
26 companies · $560 in 2025
The $560 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,260 · 2022: $73.23 · 2023: $949 · 2024: $401 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,571 · Travel and Lodging: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,570.58 |
| Travel and Lodging | $339.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,260.34 | 2021 | |
| Linvatec Corporation | $483.96 | 2023 | Colink Plating System, Quantum |
| Smith+Nephew, INC. | $251.57 | 2024-2025 | Grafix Pl, Collagenase Santyl, Regranex |
| Treace Medical Concepts, INC. | $249.36 | 2025 | |
| Horizon Therapeutics Plc | $214.42 | 2022-2023 | Krystexxa |
| Medtronic, INC. | $186.68 | 2022-2024 | Intellis Adaptivestim |
| Averitas Pharma INC. | $51.23 | 2023-2025 | Qutenza |
| Abbvie INC. | $50.65 | 2024 | |
| Paratek Pharmaceuticals, INC. | $50.44 | 2025 | Nuzyra |
| Integra Lifesciences Corporation | $42.94 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $38.17 | 2025 | Augment Injectable |
| Depuy Synthes Sales INC. | $38.09 | 2024-2025 | Healix Knotless Peek, Dynacord, Na |
| Orthofix Medical, INC. | $31.80 | 2024 | Accelstim |
| Globus Medical, INC. | $31.12 | 2025 | Senza |
| Acera Surgical, INC. | $30.26 | 2024 | Restrata Wound Matrix |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $29.50 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $28.28 | 2023 | Seglentis |
| Amgen INC. | $24.84 | 2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $24.39 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.60 | 2023 | Jublia |
| Progenacare Global, LLC | $19.35 | 2024 | |
| Ets Wound Care LLC | $18.80 | 2025 | Mirragen Advanced Wound Matrix |
| Biowound Solutions, INC. | $18.65 | 2025 | Bio-Connekt |
| Cashflow Solutions, LLC | $18.18 | 2023 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Acumed LLC | $15.49 | 2024 | Wedges, Acumed, Osteomed |
| Reapplix INC. | $14.04 | 2023 | 3c Patch Kit - Box |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Mark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.